Contextualizing & Responding to HIV Risk Behaviors Among Black Drug Offenders
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Human Immunodeficiency Virus
- Sponsor
- Columbia University
- Enrollment
- 32
- Locations
- 1
- Primary Endpoint
- Number of participants who reached at least 85% medication adherence rate.
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The purpose of this study was to pilot test the potential for improvement in antiretroviral medication adherence of a an adapted group-based, multi-session, community-based Antiretroviral Therapy (ART) adherence and risk reduction intervention, Project ADHerence Education and Risk Evaluation (ADHERE). Project ADHERE was compared to a single-session group-based medication adherence intervention, Medication Adherence and Care Engagement (MACE).
A secondary aim was to examine the impact of Project ADHERE on HIV risk behaviors (i.e., illicit drug use and unprotected sexual behavior).
This study was designed to inform, design, and pilot test the two antiretroviral medication adherence interventions for HIV-infected formerly incarcerated individuals.
Detailed Description
Formerly incarcerated Black drug offenders are at an elevated risk for HIV infection. Despite substantial research expressing the need for HIV prevention services for ex-offenders postrelease, this population has limited access to quality programming and services related to HIV risk reduction. This K01 application seeks to inform and adapt an HIV risk reduction intervention to address the needs of formerly incarcerated Black drug offenders who are being released from prisons in the New York City metropolitan area.The study will utilize qualitative and quantitative methods to inform and adapt an HIV prevention intervention for this study population.
Investigators
Tawandra Rowell-Cunsolo
Assistant Professor of Social Welfare Science
Columbia University
Eligibility Criteria
Inclusion Criteria
- •≥18 years of age
- •HIV seropositive with "detectable" viral load (VL)(defined as \>50 copies/mL)
- •history of drug use (used illicit drugs within the past year)
- •experienced incarceration in prison or jail within the past five years
Exclusion Criteria
- •living in a healthcare or assisted living facility
- •experienced incarceration longer than five years ago
Outcomes
Primary Outcomes
Number of participants who reached at least 85% medication adherence rate.
Time Frame: Over a 3-month period
Self-report data and viral loads to test for medication adherence will be collected and analyzed to yield the rate (%).
Secondary Outcomes
- Percentage of participants with HIV risk behaviors(Over a 3-month period)